A development stage company was a formal accounting classification under U.S. GAAP for a business that had not yet begun planned principal operations or had begun them without producing significant revenue. The Financial Accounting Standards Board eliminated the classification in 2014, so the label no longer carries any special reporting requirements. Pre-revenue companies today follow the same GAAP as any other entity, with the disclosure pressure that used to live under the old rules now distributed across risk and uncertainty disclosures, going concern assessments, and R&D expensing rules.
What the Classification Used to Mean
Before 2014, FASB’s Accounting Standards Codification Topic 915 defined a development stage entity and imposed specific reporting obligations on it. A company qualified when it devoted substantially all of its efforts to establishing a new business and either had not yet begun its planned principal operations or had begun them but produced no significant revenue.1Financial Accounting Standards Board. FASB Issues Standard to Improve Financial Reporting for Development Stage Entities The definition was broad enough to cover new startups and older organizations that had pivoted into something entirely new without yet earning meaningful revenue from it.
Topic 915 required these entities to present inception-to-date financial information in the income statement, cash flow statement, and statement of shareholders’ equity. Financial statements had to be labeled as those of a development stage entity, and the company had to describe the activities it was engaged in. When it exited the development stage, it had to disclose that fact in its first post-transition filing.2PwC. Development Stage Entities (Topic 915)
The reasoning was that period-to-period comparisons mean little when a company has no revenue history, so cumulative data since inception gives investors something concrete to evaluate.
Why FASB Eliminated It in 2014
In June 2014, FASB issued Accounting Standards Update No. 2014-10 and removed Topic 915 from the codification. The update eliminated all incremental financial reporting requirements for development stage entities, including the inception-to-date disclosures and the labeling requirement.3Financial Accounting Standards Board. FASB In Focus – Development Stage Entities (Topic 915) The changes took effect for public companies in reporting periods beginning after December 15, 2014, and for private entities in annual periods beginning after that same date.
FASB’s rationale came down to cost and benefit. Stakeholders told the board that the label stigmatized companies and made capital-raising harder without providing information that couldn’t be gleaned from ordinary disclosures. The inception-to-date data was expensive to compile and rarely used by analysts in ways that justified the effort. The update also amended the variable interest entity guidance in ASC Topic 810, removing a provision that had used development stage status as a factor in consolidation analysis.4IAS Plus. FASB Eliminates DSE Concept From U.S. GAAP
The practical effect is that a pre-revenue startup filing financial statements today follows the same GAAP rules as an established company. No special label, no mandatory cumulative data, no separate framework.
What Pre-Revenue Companies Must Disclose Now
The disclosure pressure didn’t disappear. FASB clarified that ASC Topic 275, which covers risks and uncertainties, applies to entities that have not commenced planned principal operations.4IAS Plus. FASB Eliminates DSE Concept From U.S. GAAP Under Topic 275, companies describe the nature of their operations, discuss significant estimates used in the financial statements, and disclose vulnerabilities stemming from concentrations in revenue sources, suppliers, or geographic markets.
For a pre-revenue company, those disclosures effectively force the same transparency that Topic 915 once mandated, just through a different mechanism. A startup with no revenue, heavy cash burn, and dependence on a single funding source will need to disclose all of that as risks and uncertainties. The footnotes carry most of the weight, describing the plan of operations, how the company intends to fund itself, and what milestones it needs to hit before becoming self-sustaining.
Going Concern Assessments
The most consequential disclosure for any pre-revenue company is whether it can survive the next twelve months. Under ASC 205-40, management must evaluate going concern each annual and interim reporting period, looking forward one year from the date the financial statements are issued. If conditions suggest the company probably cannot meet its obligations as they come due within that window, substantial doubt exists and must be disclosed.
When substantial doubt is identified, management lays out its plans to address the problem, whether that means securing additional funding, cutting expenses, or restructuring debt. If those plans alleviate the doubt, the company still discloses that doubt existed initially, along with the triggering conditions and the plans that resolved it. If the plans don’t alleviate it, the company must include an explicit statement that substantial doubt about its ability to continue as a going concern exists.
Auditors apply a parallel standard. Under PCAOB Auditing Standard 2415, the auditor evaluates whether there is substantial doubt about the entity’s ability to continue as a going concern for up to one year beyond the date of the financial statements being audited. If doubt persists after considering management’s plans, the auditor adds an explanatory paragraph to the audit report.5Public Company Accounting Oversight Board. Consideration of an Entity’s Ability to Continue as a Going Concern (AS 2415) For pre-revenue companies burning cash without an established revenue stream, this assessment happens virtually every reporting period.
How R&D Spending Runs Through the Income Statement
Research and development costs dominate the income statements of pre-revenue companies, and the accounting treatment is straightforward. Under ASC 730, all R&D costs must be recognized as an expense when incurred. Personnel costs, contract research services, and indirect costs related to R&D are all expensed immediately. Materials, equipment, and facilities acquired specifically for R&D with no alternative future use get the same treatment.
The exception involves R&D assets that have an alternative future use beyond the current project. Equipment or facilities that could be repurposed for production or other activities can be capitalized and depreciated over their useful lives, with the depreciation running through R&D expense as the assets are used in research. Intangible assets acquired in a business combination for use in R&D are also capitalized regardless of whether they have an alternative future use.
This immediate-expensing rule is why pre-revenue companies typically show large net losses even when they are executing their business plan on schedule. The net loss figure is usually a reflection of accounting rules rather than operational failure.
Tax Treatment Is a Separate Regime
The accounting treatment and the tax treatment of startup spending are completely different, and confusing them is a common mistake. For accounting, startup costs hit the income statement immediately. For tax, the IRS applies its own rules under Section 195 of the Internal Revenue Code.
A company that begins active operations can elect to deduct up to $5,000 of qualifying startup expenditures in its first year. That $5,000 allowance phases out dollar-for-dollar once total startup costs exceed $50,000, disappearing entirely at $55,000. Any startup costs not deducted in the first year must be amortized ratably over 180 months, starting with the month the business begins operations.6eCFR. 26 CFR 1.195-1 – Election to Amortize Start-Up Expenditures Organizational costs follow an identical structure, with a separate $5,000 deduction, the same $50,000 phase-out, and 180-month amortization for the excess.
The catch: if a company incurs startup costs but never begins active operations, none of those costs are deductible. Section 195 only works once the business actually launches. A company that spends two years in development and then folds never gets the tax benefit of that spending.
Research and experimental expenditures follow their own path. For tax years beginning after December 31, 2024, new Section 174A allows taxpayers to immediately deduct domestic R&E expenditures. Companies can alternatively elect to capitalize and amortize domestic R&E costs over at least 60 months.7Grant Thornton. Permanent Full Expensing for U.S. Research in OBBBA Research conducted outside the United States does not get that treatment and must still be capitalized and amortized over 15 years. Companies with offshore development teams need to plan around the domestic-versus-foreign distinction.
The Classification That Matters Now: Emerging Growth Company
For a pre-revenue company going public, the classification that actually shapes reporting today is Emerging Growth Company (EGC) status, created by the JOBS Act in 2012. EGC status provides scaled disclosure and compliance accommodations designed to make the IPO process less burdensome for smaller companies.
A company qualifies as an EGC if it has total annual gross revenues below $1.235 billion during its most recently completed fiscal year. The status lasts for five fiscal years after the IPO, unless the company hits one of the off-ramps earlier: crossing the revenue threshold, issuing more than $1 billion in non-convertible debt over a three-year period, or becoming a large accelerated filer.8U.S. Securities and Exchange Commission. Emerging Growth Companies
The benefits are real. EGCs can submit draft registration statements confidentially for SEC review before going public. They can provide two years of audited financial statements in an IPO filing instead of three, and an EGC filing a registration statement prior to its IPO may omit historical financial information that it reasonably believes won’t be required at the time of the actual offering.9U.S. Securities and Exchange Commission. Form S-1 Registration Statement Under the Securities Act of 1933 They are exempt from the Sarbanes-Oxley requirement for an external audit of internal controls and can adopt new accounting standards on the private company timeline.
A separate category, the Smaller Reporting Company (SRC), offers additional scaled disclosure for public companies with a public float below $250 million, or those with less than $100 million in annual revenue and either no public float or a public float under $700 million.10U.S. Securities and Exchange Commission. Smaller Reporting Company Definition Many pre-revenue companies going public qualify under both EGC and SRC and stack the benefits.